Dr Timothy Ryan Swofford, MD | |
624 W Interstate 30 Ste 100, Royse City, TX 75189-7566 | |
(972) 635-2173 | |
Not Available |
Full Name | Dr Timothy Ryan Swofford |
---|---|
Gender | Male |
Speciality | Family Practice |
Experience | 16 Years |
Location | 624 W Interstate 30 Ste 100, Royse City, Texas |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1639339575 | NPI | - | NPPES |
302200602 | Medicaid | TX | |
302200603 | Medicaid | TX |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | N7355 (Texas) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Texas Health Presbyterian Hospital Rockwall | Rockwall, TX | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Texas Health Physicians Group | 4385535954 | 1182 |
News Archive
Imagine shrinking to the size of a doll in your sleep. When you wake up, will you perceive yourself as tiny or the world as being populated by giants? Researchers at Karolinska Institutet in Sweden may have found the answer.
The proportion of women age 65 and over on Medicare who said that they had been screened for osteoporosis increased from 34 percent in 2001 to 64 percent in 2006, according to the latest News and Numbers from the Agency for Healthcare Research and Quality.
Protox Therapeutics Inc., a leader in the development of receptor targeted fusion proteins, today announced that it has entered into an exclusive US $75 million license agreement with Kissei Pharmaceutical Co., Ltd. for the development and commercialization of its PSA-activated pro-drug, PRX302, in Japan for BPH, prostate cancer and other diseases of the prostate. Protox retains exclusive rights to PRX302 in all other territories.
New analysis of survey data suggests that nearly 61% of people who try their first cigarette become daily smokers, at least temporarily.
› Verified 7 days ago
Entity Name | Texas Health Physicians Group |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1174573596 PECOS PAC ID: 4385535954 Enrollment ID: O20040323000759 |
News Archive
Imagine shrinking to the size of a doll in your sleep. When you wake up, will you perceive yourself as tiny or the world as being populated by giants? Researchers at Karolinska Institutet in Sweden may have found the answer.
The proportion of women age 65 and over on Medicare who said that they had been screened for osteoporosis increased from 34 percent in 2001 to 64 percent in 2006, according to the latest News and Numbers from the Agency for Healthcare Research and Quality.
Protox Therapeutics Inc., a leader in the development of receptor targeted fusion proteins, today announced that it has entered into an exclusive US $75 million license agreement with Kissei Pharmaceutical Co., Ltd. for the development and commercialization of its PSA-activated pro-drug, PRX302, in Japan for BPH, prostate cancer and other diseases of the prostate. Protox retains exclusive rights to PRX302 in all other territories.
New analysis of survey data suggests that nearly 61% of people who try their first cigarette become daily smokers, at least temporarily.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Timothy Ryan Swofford, MD 624 W Interstate 30 Ste 100, Royse City, TX 75189-7566 Ph: (972) 635-2173 | Dr Timothy Ryan Swofford, MD 624 W Interstate 30 Ste 100, Royse City, TX 75189-7566 Ph: (972) 635-2173 |
News Archive
Imagine shrinking to the size of a doll in your sleep. When you wake up, will you perceive yourself as tiny or the world as being populated by giants? Researchers at Karolinska Institutet in Sweden may have found the answer.
The proportion of women age 65 and over on Medicare who said that they had been screened for osteoporosis increased from 34 percent in 2001 to 64 percent in 2006, according to the latest News and Numbers from the Agency for Healthcare Research and Quality.
Protox Therapeutics Inc., a leader in the development of receptor targeted fusion proteins, today announced that it has entered into an exclusive US $75 million license agreement with Kissei Pharmaceutical Co., Ltd. for the development and commercialization of its PSA-activated pro-drug, PRX302, in Japan for BPH, prostate cancer and other diseases of the prostate. Protox retains exclusive rights to PRX302 in all other territories.
New analysis of survey data suggests that nearly 61% of people who try their first cigarette become daily smokers, at least temporarily.
› Verified 7 days ago
Dr. Nicole Susanne Swofford, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 6257 Fm 2642 Blvd, Royse City, TX 75189 Phone: 469-800-3670 | |
Frank Brian Cantieri, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 6257 Fm 2642 Blvd Ste 100, Royse City, TX 75189 Phone: 469-800-3670 | |
Ronald W. Jones, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 200 N. Arch St., Royse City, TX 75189 Phone: 972-636-9577 | |
Dr. Richard L Becker, DO Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 3918 Ruger Dr, Royse City, TX 75189 Phone: 469-723-6735 | |
Megan Marie Mckenna, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 616 E Lamar St, Royse City, TX 75189 Phone: 469-902-9550 Fax: 469-902-9551 |